• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Primary tumor location and mutation: key prognostic factors in surgically treated colorectal liver metastases.

作者信息

Nakayama Toshihiro, Sasaki Kazunari, Margonis Georgios Antonios

机构信息

Stanford Transplant Outcomes Research Center (STORC), Division of Abdominal Transplantation, Stanford University Medical Center, Stanford, CA, USA.

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Hepatobiliary Surg Nutr. 2025 Jun 1;14(3):502-505. doi: 10.21037/hbsn-2025-209. Epub 2025 May 21.

DOI:10.21037/hbsn-2025-209
PMID:40529931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12170000/
Abstract
摘要

相似文献

1
Primary tumor location and mutation: key prognostic factors in surgically treated colorectal liver metastases.原发性肿瘤位置与突变：手术治疗的结直肠癌肝转移的关键预后因素
Hepatobiliary Surg Nutr. 2025 Jun 1;14(3):502-505. doi: 10.21037/hbsn-2025-209. Epub 2025 May 21.
2
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.KRAS、BRAF、PI3K和TP53基因突变分析对可切除和不可切除结直肠癌肝转移的临床意义及预后相关性：当前证据的系统评价
Surg Oncol. 2018 Jun;27(2):280-288. doi: 10.1016/j.suronc.2018.05.012. Epub 2018 May 8.
3
Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.KRAS 或 BRAF 突变型结直肠癌肝转移且微卫星不稳定状态阴性患者的预后较差。
J Hepatobiliary Pancreat Sci. 2013 Feb;20(2):223-33. doi: 10.1007/s00534-012-0531-9.
4
Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.结直肠癌肝转移肝切除术后KRAS状态的预后意义因原发性结直肠癌肿瘤位置而异。
Ann Surg Oncol. 2016 Oct;23(11):3736-3743. doi: 10.1245/s10434-016-5361-6. Epub 2016 Jun 28.
5
Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.根据结直肠肝转移发生时间的不同，KRAS 突变状态对长期生存的影响也不同。
BMC Cancer. 2021 Apr 15;21(1):412. doi: 10.1186/s12885-021-08144-5.
6
Double and Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series.手术治疗的结直肠癌肝转移中的双重和多重突变：一项国际多机构病例系列研究。
Anticancer Res. 2018 May;38(5):2891-2895. doi: 10.21873/anticanres.12535.
7
The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver Metastases.KRAS 基因突变对同步结直肠肝转移瘤根治性切除术后患者预后的影响。
J Gastrointest Surg. 2019 Oct;23(10):1957-1963. doi: 10.1007/s11605-018-3978-4. Epub 2018 Oct 1.
8
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection.结直肠癌原发肿瘤与肝转移灶之间KRAS突变状态的不一致性：对根治性切除术后长期生存的影响
Cancers (Basel). 2021 Apr 29;13(9):2148. doi: 10.3390/cancers13092148.
9
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.BRAF 突变与手术治疗转移性结直肠癌肝转移患者生存和复发的关系。
JAMA Surg. 2018 Jul 18;153(7):e180996. doi: 10.1001/jamasurg.2018.0996.
10
Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.KRAS基因第12密码子特定突变与结直肠癌肝转移之间的关联
JAMA Surg. 2015 Aug;150(8):722-9. doi: 10.1001/jamasurg.2015.0313.

本文引用的文献

1
Clinical and molecular heterogeneity associated with tumor sidedness in colorectal liver metastasis: a multicenter propensity cohort study.结直肠癌肝转移中与肿瘤部位相关的临床和分子异质性：一项多中心倾向队列研究
Hepatobiliary Surg Nutr. 2024 Apr 3;13(2):214-228. doi: 10.21037/hbsn-22-285. Epub 2023 Mar 22.
2
Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.基线 ctDNA 基因突变作为转移性结直肠癌使用帕尼单抗和化疗后生存的生物标志物。
Nat Med. 2024 Mar;30(3):730-739. doi: 10.1038/s41591-023-02791-w. Epub 2024 Feb 12.
3
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated G12C.
索托拉西布联合帕尼单抗治疗携带 G12C 突变的难治性结直肠癌。
N Engl J Med. 2023 Dec 7;389(23):2125-2139. doi: 10.1056/NEJMoa2308795. Epub 2023 Oct 22.
4
Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial.结直肠癌患者肝移植的长期生存、预后因素及患者选择：一项非随机对照试验。
JAMA Surg. 2023 Sep 1;158(9):e232932. doi: 10.1001/jamasurg.2023.2932. Epub 2023 Sep 13.
5
Primary tumour side as a driver for treatment choice in RAS wild-type metastatic colorectal cancer patients: a systematic review and pooled analysis of randomised trials.在RAS野生型转移性结直肠癌患者中，原发肿瘤部位作为治疗选择的驱动因素：一项随机试验的系统评价和汇总分析
Eur J Cancer. 2023 May;184:106-116. doi: 10.1016/j.ejca.2023.02.006. Epub 2023 Feb 17.
6
Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver Metastasis.原发肿瘤位置对结直肠癌肝转移患者转移后生存的影响。
J Gastrointest Surg. 2021 Mar;25(3):650-661. doi: 10.1007/s11605-020-04855-5. Epub 2020 Nov 17.
7
Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.辅助性肝动脉灌注化疗与生存改善相关，与结直肠癌肝转移患者 KRAS 突变状态无关：674 例患者的回顾性分析。
Ann Surg. 2020 Aug;272(2):352-356. doi: 10.1097/SLA.0000000000003248.
8
The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.原发肿瘤部位的预后影响因 KRAS 突变状态而异：国际结直肠癌肝转移遗传协作组的研究。
Ann Surg. 2021 Jun 1;273(6):1165-1172. doi: 10.1097/SLA.0000000000003504.
9
Meta-analysis of the association between primary tumour location and prognosis after surgical resection of colorectal liver metastases.结直肠肝转移术后原发肿瘤部位与预后关系的荟萃分析。
Br J Surg. 2019 Dec;106(13):1747-1760. doi: 10.1002/bjs.11289. Epub 2019 Aug 6.
10
The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.原发性肿瘤位置对结直肠癌肝转移行肝切除术患者的影响。
Eur J Surg Oncol. 2018 Jun;44(6):771-777. doi: 10.1016/j.ejso.2018.02.210. Epub 2018 Mar 2.